Hypoxia-inducible factor-prolyl hydroxylase inhibitors in treatment of anemia with chronic disease
{{output}}
Anemia of chronic disease (ACD) is the most frequent clinical issue in patients with chronic disease, ACD is usually secondary to chronic kidney disease (CKD), cancer, and chronic infection, which is associated with poor health outcomes, increased morbidity an... ...
